A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma : An Eastern and Western experience

JAMA Surgery

Volumn 149, Issue 5, 2014, Pages 432-438

  Hyder, Omar ^a   Marques, Hugo ^b   Pulitano, Carlo ^c   Marsh, J Wallis ^d   Alexandrescu, Sorin ^e   Bauer, Todd W ^f   Gamblin, T Clark ^g   Sotiropoulos, Georgios C ^h   Paul, Andreas ^h   Barroso, Eduardo ^b   Clary, Bryan M ⁱ   Aldrighetti, Luca ^c   Ferrone, Cristina R ^j   Zhu, Andrew X ^j   Popescu, Irinel ^e   Gigot, Jean Francois ^k   Mentha, Gilles ^l   Feng, Shen ^m   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL CURRY CABRAL   (Portugal)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e FUNDENI CLINICAL INSTITUTE   (Romania)

^f UNIVERSITY OF VIRGINIA   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^l GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^m Eastern Hepatobiliary Surgery Hospital   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADJUVANT THERAPY; ADULT; ARTICLE; ASIA; BILE DUCT CARCINOMA; CALIBRATION; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; EUROPE; FEMALE; HEALTH CENTER; HEMIHEPATECTOMY; HUMAN; LIVER CIRRHOSIS; LIVER RESECTION; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MINOR SURGERY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; NOMOGRAM; OVERALL SURVIVAL; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; TUMOR INVASION; UNITED STATES;

ASIA; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; CROSS-CULTURAL COMPARISON; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SURVIVAL ANALYSIS; SURVIVORS; UNITED STATES;

EID: 84901307929     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.5168     Document Type: Article

References (24)

1. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):77-82. (Pubitemid 351934989)
2. Nathan H, Pawlik TM,Wolfgang CL, ChotiMA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11(11):1488-1497.
3. de Jong MC, Nathan H, Sotiropoulos GC, et al Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140-3145.
4. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
5. Steyerberg EW. Case study on survival analysis: prediction of secondary cardiovascular events. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer; 2008:436-437.
6. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364-1370.
7. Brennan MF, KattanMW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293-298. (Pubitemid 38963021)
8. Lagarde SM, Reitsma JB, Ten Kate FJ, et al. Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction. Ann Surg. 2008;248(6):1006-1013.
9. Cho CS, Gonen M, Shia J, et al. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg. 2008;206(2):281-291.
10. Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188- 1195.
11. Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153(6):811-818.
12. Chen LP, Li C,Wang C,Wen TF, Yan LN, Li B. Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology. 2012;59(118):1765-1768.
13. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10(4):288-291. (Pubitemid 37407518)
14. Liver Cancer Study Group of Japan. Intrahepatic cholangiocarcinoma. In: Classification of Primary Liver Cancer. Tokyo, Japan: Kanehara; 1997:6-7.
15. Sobin LH, Gospodarowicz MK, Wittekind CH, eds. TNM Classification of Malignant Tumours. 6th ed. Hoboken, NJ:Wiley; 2002.
16. Ferrone CR, KattanMW, Tomlinson JS, Thayer SP, Brennan MF,Warshaw AL. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23(3):7529-7535. (Pubitemid 46291816)
17. KattanMW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90(10):766-771. (Pubitemid 28259189)
18. KattanMW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20(3):791-796. (Pubitemid 34111387)
19. Meyers RH. Transformations to improve fit and prediction. In: Classical and Modern Regression With Examples. 2nd ed. Belmont, CA: Duxbury Press; 2000:293-315.
20. Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16(1):14-22.
21. Horino K, Beppu T, Komori H, et al. Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis. Hepatogastroenterology. 2012;59(116):1217-1219.
22. Cho SY, Park SJ, Kim SH, et al. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol. 2010;17(7):1823-1830.
23. JiangW, Zeng ZC, Tang ZY, et al A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Ann Oncol. 2011;22(7):1644-1652.
24. Farges O, Fuks D, Le Treut YP, et al; for the AFD-IHCC-2009 Study Group. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma. Cancer. 2011;117(10): 2170-2177.